Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Soeters, Heidi M., Dinitz-Sklar, Jill, Kulkarni, Prathit A., MacNeil, Jessica R., McNamara, Lucy A., Zaremski, Elizabeth, Chang, How-yi, Lujan, Eduardo, Granoff, Dan, Lasky, Melodee, Montana, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403061/
https://www.ncbi.nlm.nih.gov/pubmed/28418307
http://dx.doi.org/10.3201/eid2305.161870
_version_ 1783231360914161664
author Soeters, Heidi M.
Dinitz-Sklar, Jill
Kulkarni, Prathit A.
MacNeil, Jessica R.
McNamara, Lucy A.
Zaremski, Elizabeth
Chang, How-yi
Lujan, Eduardo
Granoff, Dan
Lasky, Melodee
Montana, Barbara
author_facet Soeters, Heidi M.
Dinitz-Sklar, Jill
Kulkarni, Prathit A.
MacNeil, Jessica R.
McNamara, Lucy A.
Zaremski, Elizabeth
Chang, How-yi
Lujan, Eduardo
Granoff, Dan
Lasky, Melodee
Montana, Barbara
author_sort Soeters, Heidi M.
collection PubMed
description In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.
format Online
Article
Text
id pubmed-5403061
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-54030612017-05-12 Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016 Soeters, Heidi M. Dinitz-Sklar, Jill Kulkarni, Prathit A. MacNeil, Jessica R. McNamara, Lucy A. Zaremski, Elizabeth Chang, How-yi Lujan, Eduardo Granoff, Dan Lasky, Melodee Montana, Barbara Emerg Infect Dis Research Letter In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response. Centers for Disease Control and Prevention 2017-05 /pmc/articles/PMC5403061/ /pubmed/28418307 http://dx.doi.org/10.3201/eid2305.161870 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Soeters, Heidi M.
Dinitz-Sklar, Jill
Kulkarni, Prathit A.
MacNeil, Jessica R.
McNamara, Lucy A.
Zaremski, Elizabeth
Chang, How-yi
Lujan, Eduardo
Granoff, Dan
Lasky, Melodee
Montana, Barbara
Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title_full Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title_fullStr Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title_full_unstemmed Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title_short Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
title_sort serogroup b meningococcal disease vaccine recommendations at a university, new jersey, usa, 2016
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403061/
https://www.ncbi.nlm.nih.gov/pubmed/28418307
http://dx.doi.org/10.3201/eid2305.161870
work_keys_str_mv AT soetersheidim serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT dinitzsklarjill serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT kulkarniprathita serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT macneiljessicar serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT mcnamaralucya serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT zaremskielizabeth serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT changhowyi serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT lujaneduardo serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT granoffdan serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT laskymelodee serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016
AT montanabarbara serogroupbmeningococcaldiseasevaccinerecommendationsatauniversitynewjerseyusa2016

Ejemplares similares